These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 17475367

  • 1. Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") administration in awake rats.
    Gramsbergen JB, Cumming P.
    Neurochem Int; 2007 Jul; 51(1):8-15. PubMed ID: 17475367
    [Abstract] [Full Text] [Related]

  • 2. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R, Kerans A, O'Neill B, Harkin A.
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [Abstract] [Full Text] [Related]

  • 3. The effects of co-administration of 3,4-methylenedioxymethamphetamine ("ecstasy") or para-methoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats.
    Stanley N, Salem A, Irvine RJ.
    Neuroscience; 2007 Apr 25; 146(1):321-9. PubMed ID: 17306465
    [Abstract] [Full Text] [Related]

  • 4. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
    Freezer A, Salem A, Irvine RJ.
    Brain Res; 2005 Apr 11; 1041(1):48-55. PubMed ID: 15804499
    [Abstract] [Full Text] [Related]

  • 5. Hypothyroidism alters striatal dopamine release mediated by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
    Peterson AL, Gilman TL, Banks ML, Sprague JE.
    Synapse; 2006 Apr 11; 59(5):317-9. PubMed ID: 16421905
    [Abstract] [Full Text] [Related]

  • 6. On-line monitoring of striatum glucose and lactate in the endothelin-1 rat model of transient focal cerebral ischemia using microdialysis and flow-injection analysis with biosensors.
    Gramsbergen JB, Skjøth-Rasmussen J, Rasmussen C, Lambertsen KL.
    J Neurosci Methods; 2004 Dec 30; 140(1-2):93-101. PubMed ID: 15589339
    [Abstract] [Full Text] [Related]

  • 7. Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release.
    Bankson MG, Yamamoto BK.
    J Neurochem; 2004 Nov 30; 91(4):852-9. PubMed ID: 15525339
    [Abstract] [Full Text] [Related]

  • 8. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
    Sanchez V, O'shea E, Saadat KS, Elliott JM, Colado MI, Green AR.
    J Psychopharmacol; 2004 Sep 30; 18(3):412-6. PubMed ID: 15358986
    [Abstract] [Full Text] [Related]

  • 9. The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.
    Darvesh AS, Gudelsky GA.
    Neurotoxicol Teratol; 2004 Sep 30; 26(4):571-7. PubMed ID: 15203179
    [Abstract] [Full Text] [Related]

  • 10. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
    Shioda K, Nisijima K, Yoshino T, Kuboshima K, Iwamura T, Yui K, Kato S.
    Neurotoxicology; 2008 Nov 30; 29(6):1030-6. PubMed ID: 18722468
    [Abstract] [Full Text] [Related]

  • 11. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK, Nash JF, Gudelsky GA.
    J Pharmacol Exp Ther; 1995 Jun 30; 273(3):1063-70. PubMed ID: 7791076
    [Abstract] [Full Text] [Related]

  • 12. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
    Hewton R, Salem A, Irvine RJ.
    Clin Exp Pharmacol Physiol; 2007 Oct 30; 34(10):1051-7. PubMed ID: 17714093
    [Abstract] [Full Text] [Related]

  • 13. Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats.
    O'Shea E, Escobedo I, Orio L, Sanchez V, Navarro M, Green AR, Colado MI.
    Neuropsychopharmacology; 2005 Jul 30; 30(7):1312-23. PubMed ID: 15688085
    [Abstract] [Full Text] [Related]

  • 14. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.
    Nash JF, Meltzer HY, Gudelsky GA.
    J Pharmacol Exp Ther; 1988 Jun 30; 245(3):873-9. PubMed ID: 2898523
    [Abstract] [Full Text] [Related]

  • 15. Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain.
    Darvesh AS, Yamamoto BK, Gudelsky GA.
    J Pharmacol Exp Ther; 2005 Feb 30; 312(2):694-701. PubMed ID: 15456837
    [Abstract] [Full Text] [Related]

  • 16. Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain.
    Bull EJ, Porkess V, Rigby M, Hutson PH, Fone KC.
    J Psychopharmacol; 2006 Mar 30; 20(2):272-80. PubMed ID: 16510485
    [Abstract] [Full Text] [Related]

  • 17. Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT.
    Darvesh AS, Gudelsky GA.
    Brain Res; 2005 Sep 21; 1056(2):168-75. PubMed ID: 16098955
    [Abstract] [Full Text] [Related]

  • 18. Acceleration of serotonin transporter transport-associated current by 3,4-methylenedioxymethamphetamine (MDMA) under acidic conditions.
    Yamauchi Y, Izumi T, Unemura K, Uenishi Y, Nakagawa T, Kaneko S.
    Neurosci Lett; 2007 Nov 27; 428(2-3):72-6. PubMed ID: 17949903
    [Abstract] [Full Text] [Related]

  • 19. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
    Camarasa J, Pubill D, Escubedo E.
    Brain Res; 2006 Sep 21; 1111(1):72-82. PubMed ID: 16889759
    [Abstract] [Full Text] [Related]

  • 20. 3,4-Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain.
    Darvesh AS, Shankaran M, Gudelsky GA.
    J Pharmacol Exp Ther; 2002 Apr 21; 301(1):138-44. PubMed ID: 11907167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.